Athira Pharma (ATHA)
(Delayed Data from NSDQ)
$3.21 USD
-0.04 (-1.23%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $3.22 +0.01 (0.31%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.78 | 0.00% |
Earnings Summary
For their last quarter, Athira Pharma (ATHA) reported earnings of -$0.70 per share, beating the Zacks Consensus Estimate of $-0.75 per share. This reflects a positive earnings surprise of 6.67%. Look out for ATHA's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.78 per share, reflecting a year-over-year increase of 10.34%.
Earnings History
Price & Consensus
Zacks News for ATHA
Is Stryker (SYK) Stock Outpacing Its Medical Peers This Year?
ATHA: What are Zacks experts saying now?
Zacks Private Portfolio Services